High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

NCT00003091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer
Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: recombinant interferon alfa

Sponsor

Hoag Memorial Hospital Presbyterian

Collaborators

[object Object]